AZN vs JBSS · P/E 28, $288.38B cap vs P/E 13, rev $1.18B
AstraZeneca PLC (AZN) versus John B Sanfilippo & Son Inc (JBSS) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
John B Sanfilippo & Son Inc (JBSS) is a packaged foods company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported JBSS revenue for 2026-06-25 was $1.18B. Net income was $61.9M. Revenue was up 6.2% from 2025-06-26 to 2026-06-25. JBSS currently screens at market cap $868.4M and trailing P/E 13.0.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. JBSS currently screens at market cap $868.4M and trailing P/E 13.0.
Not investment advice. Open the AZN and JBSS stock pages for the full models.
Not investment advice.